These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15246912)

  • 41. Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases.
    Daull P; Jeng AY; Battistini B
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):247-56. PubMed ID: 17878751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of endothelin-converting enzyme-1 and neutral endopeptidase in human endometrium.
    Iwase A; Ando H; Nagasaka T; Goto M; Harata T; Kikkawa F
    J Histochem Cytochem; 2007 Dec; 55(12):1229-35. PubMed ID: 17712175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats.
    Pham D; Jeng AY; Escher E; Sirois P; Battistini B
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S362-6. PubMed ID: 11078421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward an optimal joint recognition of the S1' subsites of endothelin converting enzyme-1 (ECE-1), angiotensin converting enzyme (ACE), and neutral endopeptidase (NEP).
    Inguimbert N; Coric P; Poras H; Meudal H; Teffot F; Fournié-Zaluski MC; Roques BP
    J Med Chem; 2002 Mar; 45(7):1477-86. PubMed ID: 11906289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications.
    Jeng AY; Mulder P; Kwan AL; Battistini B
    Can J Physiol Pharmacol; 2002 May; 80(5):440-9. PubMed ID: 12056551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival.
    Wengenmayer C; Krikov M; Mueller S; Lucht K; Villringer A; Hocher B; Unger T; Thoene-Reineke C
    Neurol Res; 2011 Mar; 33(2):201-7. PubMed ID: 21801596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective upregulation of endothelin converting enzyme-1a in the human failing heart.
    Ergul A; Grubbs AL; Zhang Y; Spinale FG
    J Card Fail; 2000 Dec; 6(4):314-20. PubMed ID: 11145756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
    Battistini B; Ayach B; Molez S; Blouin A; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelin-converting enzyme inhibition in the rat model of acute heart failure: heart function and neurohormonal activation.
    Rufanova VA; Pozdnev VF; Kalenikova EI; Postnikov AB; Storozhilova AN; Masenko VP; Gomazkov OA; Medvedev OS; Medvedeva NA
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1201-11. PubMed ID: 19596829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
    Bur D; Dale GE; Oefner C
    Protein Eng; 2001 May; 14(5):337-41. PubMed ID: 11438756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Daglutril for treatment of renal damage in hypertensive patients with type 2 diabetes: disappointment or hope?
    Laurent S
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):2-3. PubMed ID: 24622251
    [No Abstract]   [Full Text] [Related]  

  • 52. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
    Claing A; Neugebauer W; Yano M; Rae GA; D'Orléans-Juste P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S72-4. PubMed ID: 8587472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of endothelin production and metabolism in guinea-pig tracheal epithelial cells by peptidase inhibitors.
    Yang Q; Battistini B; D'Orléans-Juste P; Jeng AY; Sirois P
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1884-9. PubMed ID: 9196090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs.
    Honoré JC; Plante M; Bkaily G; Rae GA; D'Orléans-Juste P
    Br J Pharmacol; 2002 Jul; 136(6):819-28. PubMed ID: 12110606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo.
    Fecteau MH; Honoré JC; Plante M; Labonté J; Rae GA; D'Orléans-Juste P
    Hypertension; 2005 Jul; 46(1):87-92. PubMed ID: 15956117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery.
    Tirapelli CR; Casolari DA; Yogi A; Tostes RC; Legros E; Lanchote VL; Uyemura SA; de Oliveira AM
    Alcohol; 2007 Mar; 41(2):77-85. PubMed ID: 17466482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX.
    Turner AJ; Tanzawa K
    FASEB J; 1997 Apr; 11(5):355-64. PubMed ID: 9141502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.
    Wang X; Ohnishi M; Wada A; Tsutamoto T; Sawaki M; Fujii M; Matsumoto T; Yamamoto T; Kurokawa K; Yamada H; Kinoshita M
    Life Sci; 2001 Oct; 69(21):2477-88. PubMed ID: 11693256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.